Genentech BioOncology is leading the fight against cancer and has over 40 molecules in the pipeline.
Visit this comprehensive page to explore our robust oncology pipeline and find additional information on early and late-stage developments.
Explore the Met signaling pathway, which is dysregulated in many malignancies.
This section provides an in depth look at Met and it’s potential as a biomarker in the treatment of cancer.
Access educational resources about Glycoengineering in Research B-cell.
Learn more about the importance of PD-L1 and its relationship to cancer.
Welcome to Genentech BioOncology.com, a centralized destination that provides access to information about our Oncology Pipeline. This web site is intended for US Health Care Professionals.
Visit InformationAboutCancer.com to learn about a unique website that brings information, support, and resources about cancer right to your patient’s fingertips.
Get started© 2011 Genentech USA, Inc. All rights reserved
